EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS PREDICTS BONE METASTASIS IN PATIENTS PRESENTING WITH RENAL CELL CARCINOMA: IMPLICATION FOR PREOPERATIVE BONE SCANS-Reference-Cited by-同舟云学术

EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS PREDICTS BONE METASTASIS IN PATIENTS PRESENTING WITH RENAL CELL CARCINOMA: IMPLICATION FOR PREOPERATIVE BONE SCANS

Published:2004-09 Issue:3 Volume:172 Page:867-870
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

SHVARTS OLEG¹,LAM JOHN S.¹,KIM HYUNG L.¹,HAN KEN-RYU¹,FIGLIN ROBERT¹,BELLDEGRUN ARIE¹

Affiliation:

1. From the Division of Urologic Oncology, Department of Urology, David Geffen School of Medicine at University of California-Los Angeles, Los Angeles, California

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference17 articles.

1. Cancer statistics, 2003;Jemal;CA Cancer J Clin,2003

2. Diagnosis and management of renal cell carcinoma: a clinical and pathologic study of 309 cases;Skinner;Cancer,1971

3. Value of routine radionuclide bone scans in renal cell carcinoma;Blacher;Urology,1985

4. Bone scintigraphy in the initial staging of patients with renal-cell carcinoma: concise communication;Rosen;J Nucl Med,1984

5. Osseous metastases secondary to renal cell carcinoma;Swanson;Urology,1981

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transarterial chemoembolization plus camrelizumab is an effective and tolerable bridging therapy for patients with intermediate‑stage hepatocellular carcinoma: A pilot study;Oncology Letters;2023-09-14

2. Role of Primary and Metastasis-Directed Stereotactic Radiation Therapy for Advanced Renal Cell Carcinoma;Integrating Multidisciplinary Treatment for Advanced Renal Cell Carcinoma;2023

3. The Emerging Role of Radiation Therapy in Renal Cell Carcinoma;Cancers;2022-09-27

4. The Evolving Role of Metastasectomy for Patients with Metastatic Renal Cell Carcinoma;Urologic Clinics of North America;2020-08

5. Combined use of apatinib mesylate and vinorelbine versus vinorelbine alone in recurrent or metastatic triple-negative breast cancer: study protocol for a randomized controlled clinical trial;Trials;2020-05-24